Clinical Trials Directory

Trials / Completed

CompletedNCT02237989

Effects Of Native Collagen Type 2 Treatment

Effects Of Native Collagen Type 2 Treatment In Knee Osteoarthritis : A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Eskisehir Osmangazi University · Academic / Other
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to evaluate symptomatic efficacy of native collagen type 2 on joint pain and function and its effects on urinary biological markers related to cartilage degeneration in patients with knee osteoarthritis.

Detailed description

39 patients diagnosed with knee osteoarthritis were separated into two groups. The 1st group includes 19 patients given 1500mg/day paracetamol, the 2nd group consists of 20 patients given 1500mg/day paracetamol and 10mg/day native collagen type 2 for three months.Pretreatment and posttreatment Visual Analog Scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), 20-m walking time and Short Form-36 (SF-36), Coll2-1, Coll2-1NO2 and Fibulin-3 levels in urine were compared.

Conditions

Interventions

TypeNameDescription
DRUGparacetamol1500 mg
DRUGparacetamol+native collagen type 2paracetamol (1500 mg) + native collagen type 2 (10mg)

Timeline

Start date
2013-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2014-09-12
Last updated
2020-09-18
Results posted
2020-09-18

Source: ClinicalTrials.gov record NCT02237989. Inclusion in this directory is not an endorsement.